Kurz gefasst
Fachartikel in der Zeitschrift JAMA, 2024. Verfasst von Gregory Curfman. Beteiligte Einrichtung: Executive Editor, JAMA , Chicago, Illinois. Hauptthemen laut MEDLINE: Fractures, Bone, Alendronate, Bone Density Conservation Agents, Hip Fractures. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
This Viewpoint discusses the ongoing lawsuit between plaintiffs who had been affected by atypical femoral fractures while receiving alendronate and the drug manufacturer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Fractures, BoneAlendronateBone Density Conservation AgentsHip FracturesDrug LabelingHumansUnited StatesUnited States Food and Drug AdministrationBone RemodelingFractures, SpontaneousDrug Approval
Substanzen
AlendronateBone Density Conservation Agents
Autor:innen und Institutionen
- Executive Editor, JAMA , Chicago, Illinois.
Zitieren
APA
Curfman, G. (2024). Fosamax Fractures—Justice Has Not Been Served. JAMA. https://doi.org/10.1001/jama.2024.6077
Vancouver
Curfman G. Fosamax Fractures—Justice Has Not Been Served. JAMA. 2024. doi:10.1001/jama.2024.6077
BibTeX
@article{Curfman2024,
author = {Curfman, Gregory},
title = {Fosamax Fractures—Justice Has Not Been Served},
journal = {JAMA},
year = {2024},
doi = {10.1001/jama.2024.6077}
}
EUVIMED